Kevin Kris Warnakula Olesen (Kevin K W Olesen)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Venues

European journal of preventive cardiology

European journal of clinical investigation

Journal of the American Heart Association

European heart journal. Cardiovascular pharmacotherapy

Aarhus Universitet

Aarhus Universitet Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Universitet Dec 01 2017

Denmark

PhD student :: Department of Cardiology, Institute of Clinical Medicine

Aarhus Universitetshospital Feb 01 2017

Denmark

Research assistent :: Department of Cardiology

Lægerne i Langå Aug 01 2016

Denmark

Junior doctor

Regionshospitalet Randers Feb 01 2016

Denmark

Junior doctor :: Department of emergenzy medicine

Aarhus Universitetshospital Sep 01 2014 - Aug 31 2015

Denmark

Research year student :: Department of Cardiology

Education History

Aarhus Universitet Health Jan 24 2008 - Jan 15 2016

Denmark

PHD

Publications

Malene Kærslund Hansen, Martin Bødtker Mortensen, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Reimar Wernich Thomsen, Michael Maeng
Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: The Western Denmark Heart Registry. European journal of preventive cardiology (2024)
Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Christine Gyldenkerne, Reimar Wernich Thomsen, Janne Kaergaard Mortensen, Steen Dalby Kristensen, Michael Mæng
Diabetes and Coronary Artery Disease as Risk Factors for Dementia. European journal of preventive cardiology (2024)
Bent Roni Ranghøj Nielsen, Kasper Pryds, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Christine Gyldenkerne, Jens Cosedis Nielsen, Gerhard Hindricks, Nikolaos Dagres, Michael Mæng
Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR. Journal of the American Heart Association 13 (14) (2024)
Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to Baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy (2024)
Malene Kærslund Hansen, Martin Bødtker Mortensen, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Reimar Wernich Thomsen, Michael Maeng
Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: The Western Denmark Heart Registry. European journal of preventive cardiology (2024)
Bent Roni Ranghøj Nielsen, Kasper Pryds, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Christine Gyldenkerne, Jens Cosedis Nielsen, Gerhard Hindricks, Nikolaos Dagres, Michael Mæng
Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR. Journal of the American Heart Association 13 (14) (2024)
Malene Kærslund Hansen, Martin Bødtker Mortensen, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Reimar Wernich Thomsen, Michael Maeng
Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: the Western Denmark Heart Registry. European journal of preventive cardiology 31 (10) (2024)
Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Christine Gyldenkerne, Reimar Wernich Thomsen, Janne Kaergaard Mortensen, Steen Dalby Kristensen, Michael Mæng
Diabetes and Coronary Artery Disease as Risk Factors for Dementia. European journal of preventive cardiology (2024)
Bent Roni Ranghøj Nielsen, Kasper Pryds, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Christine Gyldenkerne, Jens Cosedis Nielsen, Gerhard Hindricks, Nikolaos Dagres, Michael Mæng
Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR. Journal of the American Heart Association 13 (14) (2024)
Bent Roni Ranghøj Nielsen, Kasper Pryds, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Christine Gyldenkerne, Jens Cosedis Nielsen, Gerhard Hindricks, Nikolaos Dagres, Michael Mæng
Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR. Journal of the American Heart Association (2024)
Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Guilian Birindwa, Michael Maeng, Pernille Gro Thrane, Christine Gyldenkerne, Reimar Wernich Thomsen, Kevin Kris Warnakula Olesen
Causes of Excess Mortality in Diabetes Patients Without Coronary Artery Disease: A Cohort Study Revealing Endocrinologic Contributions. Clinical epidemiology 16 (2024)
Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt, Salim Yusuf, Eva Muehlhofer, John W Eikelboom, Michael Maeng
Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Pernille Tilma Tonnesen, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Christine Gyldenkerne, Christian Daugaard Peters, Niels Henrik Buus, Michael Maeng
Absence of Coronary Artery Disease is a Strong Negative Predictor of Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease. Clinical epidemiology 15 (2023)
Kevin Kris Warnakula Olesen, Sonia Anand, Troels Thim, Christine Gyldenkerne, Michael Maeng
Microvascular disease increases the risk of lower limb amputation - A Western Danish cohort study. European journal of clinical investigation 52 (10) (2022)
Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Martin Bødtker Mortensen, Christine Gyldenkerne, Troels Thim, Bjarne Linde Nørgaard, Jesper Møller Jensen, Steen Dalby Kristensen, Jens Cosedis Nielsen, John William Eikelboom, Michael Mæng
Antithrombotic treatment beyond one year after percutaneous coronary intervention in patients with atrial fibrillation. European heart journal. Cardiovascular pharmacotherapy (2022)
Kevin Kris Warnakula Olesen, Morten Madsen, Christine Gyldenkerne, Pernille Gro Thrane, Troels Thim, Lisette Okkels Jensen, Hans Erik Bøtker, Henrik Toft Sørensen, Michael Maeng
Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study. Cardiovascular diabetology 20 (1) (2021)
Kevin Kris Warnakula Olesen, Christine Gyldenkerne, Troels Thim, Reimar Wernich Thomsen, Michael Maeng
Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry. BMJ open diabetes research & care 9 (1) (2021)
Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Jens Cosedis Nielsen, Lisette Okkels Jensen, Morten Madsen, Troels Thim, Steen Dalby Kristensen, Gregory Yoke Hong Lip, Michael Mæng
CHA2 DS2 -VASc impact on risk following percutaneous coronary intervention in atrial fibrillation. European journal of clinical investigation (2021)
Christine Gyldenkerne, Jakob S Knudsen, Kevin Kris Warnakula Olesen, Henrik T Sørensen, Hans E Bøtker, Reimar Wernich Thomsen, Michael Maeng
Nationwide Trends in Cardiac Risk and Mortality in Patients With Incident Type 2 Diabetes: A Danish Cohort Study. Diabetes care (2021)
Morten Würtz, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, John William Eikelboom, Moman Aladdin Mohammad, David Erlinge, Steen Dalby Kristensen, Michael Maeng
Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score. European heart journal (2021)
Brian Bridal Løgstrup, Kevin Kris Warnakula Olesen, Dzenan Masic, Christine Gyldenkerne, Pernille Gro Thrane, Torkell J Ellingsen, Hans Erik Bøtker, Michael Maeng
Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease. Annals of the rheumatic diseases 79 (9) (2020)
Brian Bridal Løgstrup, Kevin Kris Warnakula Olesen, Dzenan Masic, Christine Gyldenkerne, Pernille Gro Thrane, Torkell J Ellingsen, Hans Erik Bøtker, Michael Maeng
Response to 'Correspondence on 'Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease" by Jong et al. Annals of the rheumatic diseases (2020)
Kamilla Steensig, Kevin Kris Warnakula Olesen, Troels Thim, Jens C Nielsen, Morten Madsen, Svend E Jensen, Lisette O Jensen, Steen D Kristensen, Gregory Y H Lip, Michael Mæng
Predicting stroke in patients without atrial fibrillation. European journal of clinical investigation (2019)
Kevin Kris Warnakula Olesen, Morten Madsen, Gregory Y H Lip, Gro Egholm, Troels Thim, Lisette Okkels Jensen, Bent Raungaard, Jens Cosedis Nielsen, Hans Erik Bøtker, Henrik Toft Sørensen, Michael Maeng
Coronary artery disease and risk of adverse cardiac events and stroke. European journal of clinical investigation 47 (11) (2017)

Kevin Kris Warnakula Olesen.css-eqlu8i{font-size:small;padding-left:4px;} (Kevin K W Olesen)

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin Kris Warnakula Olesen (Kevin K W Olesen)